Differential platelet activation through an interaction with spike proteins of different SARS-CoV-2 variants
Description
COVID-19 disease is associated with an increased risk of thrombotic complications, which contribute to high short-term mortality. Patients with COVID-19 demonstrate enhanced platelet turnover and reactivity, which may have a role in the development
